A survey of young women's perceptions of the influence of the Levonorgestrel-Intrauterine System or copper-intrauterine device on sexual desire

被引:6
作者
Malmborg, Agota
Brynhildsen, Jan
Hammar, Mats
机构
[1] Linkoping Univ, Univ Hosp, Dept Obstet & Gynaecol, SE-58185 Linkoping, Sweden
[2] Linkoping Univ, Univ Hosp, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden
关键词
Contraception; Intrauterine contraceptives; Lng-IUS; Cu IUD; Sexual desire; Sexual function; QUALITY-OF-LIFE; IMPLANTABLE CONTRACEPTIVES; SATISFACTION; CONTINUATION;
D O I
10.1016/j.srhc.2019.06.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: Few studies, with contradictory results, evaluate intrauterine contraceptives (IUC) and sexual function specifically. This study compares perception of sexual desire related to IUC use and aspects of sexual function in women who use the Lng-IUS with those using the Cu-IUD. Study design: A secondary analysis regarding IUC use based on a larger cross-sectional survey of contraceptive use in Sweden, conducted in 2013. In total, 153 IUC users (103 Cu-IUD and 50 Lng-IUS users) answered the questionnaire. The only inclusion criterion was intrauterine contraceptive use. Main outcome measures: Were self-reported sexual desire changes related to contraceptive method. We also analysed aspects of sexual functioning; sexual desire level, sexual activity, orgasm frequency, satisfaction with sex life and satisfaction of desire level. Results: A negative effect on sexual desire due to contraceptive method was reported by 28% of the Lng-IUS users and by 10.1% of the Cu-IUD users (p < 0.05). Results were more marked after adjusting for age, body mass index, depression, parity, switching behaviour, and partnership (OR 5.0; CI: 1.8-13.8). The adjusted odds of reporting low sexual desire level (never or almost never feeling sexual desire) (OR 3.5; CI: 1.1-11.2) as well as low satisfaction with sex life (OR 2.7; CI: 1.2-6.3) was higher in the Lng-IUS group (adjusted for same confounders as above). Conclusions: The women in this study using the Lng-IUS more often report negative sexual desire effects of their contraception as well as lower sexual desire level compared with women using the Cu-IUD.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 38 条
  • [21] Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study
    Suhonen, S
    Haukkamaa, M
    Jakobsson, T
    Rauramo, I
    CONTRACEPTION, 2004, 69 (05) : 407 - 412
  • [22] A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls
    Bahamondes, Luis
    Brache, Vivian
    Meirik, Olav
    Ali, Moazzam
    Habib, Ndema
    Landoulsi, Sihem
    HUMAN REPRODUCTION, 2015, 30 (11) : 2527 - 2538
  • [23] Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism-a randomized comparative study
    Ng, Ying Woo
    Liang, Shen
    Singh, Kuldip
    CONTRACEPTION, 2009, 79 (01) : 24 - 28
  • [24] Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5mg) after abortion for unintended pregnancy
    Caruso, Salvatore
    Cianci, Stefano
    Vitale, Salvatore Giovanni
    Fava, Valentina
    Cutello, Silvia
    Cianci, Antonio
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2018, 23 (01) : 24 - 31
  • [25] The effect of the copper intrauterine device (Cu-IUD) and the injectable depomedroxyprogesterone acetate (DMPA) use on women's sexual satisfaction and depression
    Mohammadi-Pasand, Samaneh Hagh
    Farnam, Farnaz
    Damghanian, Maryam
    NURSING PRACTICE TODAY, 2020, 7 (01): : 53 - 60
  • [26] Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
    de Oliveira, Elaine Cristina Fontes
    Rocha, Ana Luiza Lunardi
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (11): : 654 - 660
  • [27] Conservative Treatment With Medroxyprogesterone Acetate Plus Levonorgestrel Intrauterine System for Early-Stage Endometrial Cancer in Young Women Pilot Study
    Kim, Mi Kyung
    Yoon, Bo Sung
    Park, Hyun
    Seong, Seok Ju
    Chung, Hyun Hoon
    Kim, Jae Weon
    Kang, Soon Beom
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 673 - 677
  • [28] Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device?
    Lete, Inaki
    del Carme Cuesta, Maria
    Marin, Juan M.
    Martinez, Miguel
    Bermejo, Asuncion
    Anna, Roberto
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 154 (01) : 67 - 70
  • [29] The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia:: a 5-year randomised controlled trial
    Halmesmaki, K.
    Hurskainen, R.
    Teperi, J.
    Grenman, S.
    Kivela, A.
    Kujansuu, E.
    Tuppurainen, M.
    Yliskoski, M.
    Vuorma, S.
    Paavonen, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (05) : 563 - 568
  • [30] Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial
    Jennifer Deese
    Pai Lien Chen
    Xiaoming Gao
    Renee Heffron
    Marcia Hobbs
    Dana Lapple
    Heather Jaspan
    Ashley Miller
    Gonasagrie Nair
    Maricianah Onono
    Thesla Palanee-Phillips
    Krishnaveni Reddy
    Markus J. Steiner
    AIDS and Behavior, 2023, 27 : 978 - 983